Obese mice whose fat cells were genetically altered to produce an increased amount of the glucose-dependent insulinotropic ...

Promising early data from an experimental trial of a new obesity treatment pill has sent shares of Danish pharmaceutical Novo Nordisk skyrocketing, Bloomberg reports. The drug, called amycretin ...

Takeda and Orexigen have been given FDA clearance to market their obesity ... also be a new randomised double-blind, placebo-controlled study to evaluate the effects of long-term treatment with ...

Then her provider referred her to see physician assistant Cody Baxter in 2021 ... an obesity specialist, to see if he could recommend more helpful treatment. He steered her toward the new medications.

It was also advancing a Hepatitis B treatment ... new CEO, Vipin Garg, who joined Altimmune a few months prior in November 2018. In January 2022, the FDA cleared Pemvidutide for clinical obesity ...

a new study finds. Data on almost 17 million adults nationwide showed the obesity rate —which has been rising for years—fell from 46.2% of adults in 2021 to 45.6% in 2023, Harvard University ...

Eli Lilly has launched a unique website to connect U.S. patients seeking obesity treatment to doctors, dieticians and its new weight-loss drug, Zepbound. The drugmaker said Thursday it will use ...